Relapsed Chronic Lymphocytic Leukemia

Relapsed Chronic Lymphocytic Leukemia is the indication for 4 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as: relapse Chronic lymphocytic leukemia · Relapsed CLL · chronic, relapsed Lymphocytic Leukemia · Chronic Lymphoid Leukemia in Relapse · CLL, Relapsed
Classified under: Hemic and Lymphatic Diseases
Immune System Diseases
Neoplasms
Indicated drugs: Duvelisib
Idelalisib
Lisocabtagene maraleucel
Pirtobrutinib

Resolves to

Vocabularies

SNOMED CT122961000119105MedDRA10008961UMLSC0854802

What you can answer from here — as of October 24, 2026

4Indicated drugsWith each drug's targets and mechanism

Listed above

4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

18Clinical trialsPhase, status and sponsor resolved per trial

3Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Relapsed Chronic Lymphocytic Leukemia share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.